Specifically, it is possible that the increase of synchronous lung metastasis in prostate cancer arose more from the decreasing popularity of prostate-specific antigen screening, leading to more advanced disease at presentation (32, 33). The gene discussed is KLK3; the disease is prostate carcinoma.